Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease.

Twine NA, Janitz K, Wilkins MR, Janitz M.

PLoS One. 2011 Jan 21;6(1):e16266. doi: 10.1371/journal.pone.0016266.

4.

Apolipoprotein E and Alzheimer's disease: a review of recent studies.

Higgins GA, Large CH, Rupniak HT, Barnes JC.

Pharmacol Biochem Behav. 1997 Apr;56(4):675-85. Review.

PMID:
9130294
5.

Genetic analysis of vascular factors in Alzheimer's disease.

Wakutani Y, Kowa H, Kusumi M, Yamagata K, Wada-Isoe K, Adachi Y, Takeshima T, Urakami K, Nakashima K.

Ann N Y Acad Sci. 2002 Nov;977:232-8. Review.

PMID:
12480755
6.

[Causative genes in Alzheimer's disease].

Urakami K, Wakutani Y, Wada-Isoe K, Yamagata K, Adachi Y, Nakashima K.

Nihon Ronen Igakkai Zasshi. 2001 Mar;38(2):117-20. Review. Japanese.

7.

Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics?

Sutherland GT, Janitz M, Kril JJ.

J Neurochem. 2011 Mar;116(6):937-46. doi: 10.1111/j.1471-4159.2010.07157.x. Epub 2011 Jan 19. Review.

8.

Splicing in the human brain.

Zaghlool A, Ameur A, Cavelier L, Feuk L.

Int Rev Neurobiol. 2014;116:95-125. doi: 10.1016/B978-0-12-801105-8.00005-9. Review.

PMID:
25172473
9.

Analysis of RNA from Alzheimer's Disease Post-mortem Brain Tissues.

Clement C, Hill JM, Dua P, Culicchia F, Lukiw WJ.

Mol Neurobiol. 2016 Mar;53(2):1322-8. doi: 10.1007/s12035-015-9105-6. Epub 2015 Jan 29. Review.

10.

Lessons from non-canonical splicing.

Sibley CR, Blazquez L, Ule J.

Nat Rev Genet. 2016 Jul;17(7):407-421. doi: 10.1038/nrg.2016.46. Epub 2016 May 31. Review.

11.

Understanding complex transcriptome dynamics in schizophrenia and other neurological diseases using RNA sequencing.

Wang X, Cairns MJ.

Int Rev Neurobiol. 2014;116:127-52. doi: 10.1016/B978-0-12-801105-8.00006-0. Review.

PMID:
25172474
12.

Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.

Borjabad A, Volsky DJ.

J Neuroimmune Pharmacol. 2012 Dec;7(4):914-26. doi: 10.1007/s11481-012-9409-5. Epub 2012 Oct 12. Review.

13.

Pathway analysis of the human brain transcriptome in disease.

Kavanagh T, Mills JD, Kim WS, Halliday GM, Janitz M.

J Mol Neurosci. 2013 Sep;51(1):28-36. doi: 10.1007/s12031-012-9940-0. Epub 2012 Dec 22. Review.

PMID:
23263795
14.

Transcriptomic changes in brain development.

Dillman AA, Cookson MR.

Int Rev Neurobiol. 2014;116:233-50. doi: 10.1016/B978-0-12-801105-8.00009-6. Review.

15.

The analytical landscape of static and temporal dynamics in transcriptome data.

Oh S, Song S, Dasgupta N, Grabowski G.

Front Genet. 2014 Feb 20;5:35. doi: 10.3389/fgene.2014.00035. eCollection 2014. Review.

16.

Gene expression profiling in the human alcoholic brain.

Warden AS, Mayfield RD.

Neuropharmacology. 2017 Aug 1;122:161-174. doi: 10.1016/j.neuropharm.2017.02.017. Epub 2017 Mar 15. Review.

PMID:
28254370

Supplemental Content

Support Center